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1 Introduction
Diabetes mellitus is a high risk complication
of pregnancy. When long standing diabetes is
complicated by diabetic nephropathy, the man-
agement of pregnancy is even more compli-
cated.
Chronic renal disease is generally associated
with menstrual irregularity, infertility and fetal
wastage [16]. In the past the successful outcome
of these pregnancies was universally accepted
to be poor [11, 17], and pregnancy was contra-
indicated in such patients mainly due to acceler-
ated deterioration of renal function, high peri-
natal mortality rates, as well as a higher inci-
dence of congenital malformations, and poor
prognosis for the newborn [23]. In view of re-
cent stress on maternal normoglycemia all dur-
ing pregnancy and in the preconceptional peri-
od, improved outcome of diabetic pregnancies
has been secured [8, 10, 18, 22]. Nevertheless,
when the woman in whom diabetes is compli-
cated by diabetic nephropathy desires children,
the situation must be seriously evaluated. Abso-
lute contraindications based on renal function,
degree of hypertension, additional vasculopa-
thies, intervention policies when problems arise,
and maintenance of normoglycemia, are all is-
sues that should be considered [12].
The purpose of this study was to reexamine
the management of the pregnant diabetic with
© 1986 by Walter dc Gruyter & Co. Berlin - New York
Curriculum vitae
Dov DICKER, M.D. was
born in 1951. He was gra-
duated from Tel·Aviv Uni-
versity Medical School in
1976. Subsequently he has
been training in the De-
partment of Obstetrics and
Gynecology at the Golda
Meir Medical Center
(Chief Prof. J. Goldman)
Petah-Tikva, Israel.
He is at present Senior
Resident and in charge of the special Diabetic Pregnancy
Clinic of the Medical Center.
nephropathy on the basis of our findings, and
reevaluate the fetal and neonatal prognosis.
2 Material and methods
Between the years 1981—1984, 71 pregnant in-
sulin-dependent-diabetic (IDD) women were
treated at the High-Risk Unit of the Golda
Meir Medical Center, in association with the
Institute of Pediatric and Adolescent Endocri-
nology, Division of Juvenile Diabetes Beilinson
Medical Center, in Israel. In 5 patients 7.0 per-
cent diabetic nephropathy (White's class F) was
diagnosed on the basis of persistent proteinuria
(> 400mg/24h).
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Proteinuria was detected prior to pregnancy
in 3 patients (60%), and at an early stage of
pregnancy in the others. Renal biopsies were
not performed to confirm the diagnosis of dia-
betic glomerulopathy. Spontaneous abortion
occurred in one women and no elective abor-
tions were performed.
The strategy of our diabetic pregnancy program
has been reported in detail [2]. All patients were
maintained with normoglycemia prior to and
throughout the period of organogenesis. In
three patients blood glucose normalization was
achieved by optimized conventional mixed in-
sulin therapy with NPH and regular insulin
injections, twice daily, with additional adminis-
tration of regular insulin according to need and
strict diet. The other two patients were treated
with continuous insulin infusion (Autosyringe
AS-6C) as well as strict diet resulting in excel-
lent diabetic control.
Since class F diabetic patients have a greater
chance of developing uterine vascular disease,
frequent periods of bed rest, (in the lateral
position), were recommended after twenty
weeks' gestation in order to increase cardiac
output and uterine blood flow. Renal function
was assessed by routine laboratory methods,
and followed up to 12 months after pregnancy.
Hypertension (blood pressure > 140/90 mm
Hg) was treated with hydralazine or methyldo-
pa. Patients with substantially impaired renal
function, persistent hypertension or suspected
fetal jeopardy were hospitalized at 24 — 33
weeks' gestation, whereas, patients without
these complications were hospitalized routinely
at 34-37 weeks.
Evaluation of fetal well-being included monthly
serial ultrasound imaging for fetal growth or
anomalies starting at 8 — 10 weeks' gestation.
Daily fetal movements count (DFMC) [25] after
20 — 22 weeks' gestation, non-stress-test (NST)
twice a week during the early third trimester
period (28 — 33 weeks' gestation), and four
times a week during the late third trimester
(34—37 weeks' gestation). Patients with suspi-
cious NST were followed by contraction stress
test (CST). Moreover, fetal condition was as-
sessed weekly by the fetal biophysical profile
[15]; lung maturity was evaluated by means of
lung profile [14] and amniotic fluid mircoviscos-
ity [1]. Timing of delivery was individualized on
the basis of balanced evaluation of maternal
condition considering renal function and hyper-
tension, as well as signs of fetal jeopardy man-
ifested by diminution of daily fetal movements
count, pathological NST, positive CST, low bio-
physical score, severe intrauterine-growth-re-
tardation, (IUGR) and fetal pulmonary matur-
ity. The route of delivery was individualized
according to maternal and fetal condition.
3 Results
Clinical data, mean blood pressure values, renal
function and pregnancy outcome are summar-
ized in tables I —III.
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The preconceptional range of creatinine clear-
ance in our patients was 48 — 82 ml/min. It re-
mained stable throughout pregnancy, and did
not demonstrate the expected progressive in-
crease for pregnancy. Proteinuria increased dra-
matically in the third trimester while the crea-
tinine clearance had the expected inverse
relationship to proteinuria and to serum crea-
tinine concentration. Serum creatinine re-
mained below the value of 1.0 mg/dl in the third
trimester in two women, and was elevated to
1.4—1.8 mg/dl in two other patients.
Of the four women who began pregnancy with
normal blood pressure two developed super-
imposed hypertension in the second half of the
second and third trimester of pregnancy. One
woman started pregnancy with elevated blood
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pressure of 140/90 mm Hg with superimposed
malignant hypertension of 160/110 mm Hg dur-
ing the third trimester. Despite antihypertensive
treatment these women had more severe pro-
teinuria and lower creatinine clearance than the
normotensive patients.
The mean increase in insulin requirement dur-
ing pregnancy was 28 ± 12 units, (range 10 to
46 units), and the control of hyperglycemia was
no more difficult than in our diabetic patients
with normal kidney function.
Proliferative retinopathy was diagnosed and
treated prior to pregnancy by laser photocoag-
ulation in two of the patients.
All patients were available for clinical studies
of renal function 6 — 12 months after pregnancy
(table II e). Proteinuria decreased more than 50
percent from the elevated levels of the third
trimester in all patients: whereas, creatinine
clearance levels and serum creatinine remained
about the same.
Diastolic hypertension persisted after pregnan-
cy in two patients and resolved in one patient.
Two normotensive patients retained normal
values after pregnancy. In three women preg-
nancy was complicated by severe hypertension
and all underwent delivery by cesarean section
at 34 — 35 weeks' gestation; the infants were
appropriate for gestationaL· age. Antepartum
fetal distress suspected on the basis of diminu-
tion of fetal movements, suspicious NST and
positive CST in one patient at 34 weeks' gesta-
tion (Case No. 2) were one more indication
for premature abdominal delivery. Delivery was
vaginal in one patient with polyhydramnions
and overdistended uterus, who developed spon-
taneous labor at 36 weeks' gestation, and deli-
vered a large for gestational age infant. Birth
weight, adjusted for gestational age, was inver-
sely relatet to maternal diastolic pressure and
creatinine clearance in the third trimester. Two
infants, delivered at 34 and 35 weeks' gestation,
developed respiratory distress syndrome
(RDS), one of them despite maternal dexameth-
asone treatment. There was no evidence for
congenital malformations, and all infants sur-
vived.
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4 Comment
The responsibility of parenthood must be pre-
sented to the couple considering pregnancy,
especially if proteinuria is found in the patient.
Both the mother and infant may be adversely
affected by the pregnancy. According to the
literature, once continuous proteinuria devel-
ops, end-stage kidney disease follows. Further-
more, the fact that proteinuria is an ominous
sign was put forth by JONES' study [7] in which
less than 28 percent of diabetic patients lived
longer than ten years.
MOGENSEN et al [20] calculated that even when
the patient had a normal creatinine clearance
at the onset of proteinuria, she would lose aver-
age of 11 ml/min/year. Consequently, the hus-
band must be advised that he may be a single
parent and must determine if this outlook
would change his mind about becoming a
father.
The data on improvement of kidney function
with improvement of glucose levels in the
patient with diabetes mellitus is controversial
[3, 6] and no promises on longevity can be given
to the couple. The establishment of normogly-
cemia must be part of the prepregnancy coun-
seling; it .cannot be used as a guarantee for
prolonged life, but only an absolute prerequisite
for pregnancy planning.
Recently, excellent maternal glucose control has
been linked to the absence of congenital malfor-
mations in offspring of IDD mothers. MILLER
et al [19] noted a 30 percent increase in congeni-
tal malformations in infants born of women
with elevated glycosylated hemoglobin levels at
the time of organogenesis (the first 8 — 10 weeks
of pregnancy). FUHRMANN and coworkers [4]
reported no increased incidence of congenital
anomalies over that seen in the nondiabetic
control group, when diabetic women* achieved
strict normoglycemia prior to and throughout
the period of organogenesis. The older litera-
ture [24] relates a prevalence of congenital an-
omalies in the infant of the diabetic mother to
White's classification. The higher the White
group, the greater the risk of producing a mal-
formed infant.
Therefore, a woman with diabetic nephropathy,
considered by most a "high White class" who
is not normoglycemic at the time of organog-
enesis, would have the highest risk of any dia-
betic woman.
The second concern for the infant of the dia-
betic mother is the size and metabolic status of
the infant. Most of the earlier literature claims
that patients with diabetic nephropathy have
growth-retarded infants [26]. The hypothesis
was that maternal hypertension and vasculopa-
thy produced an ischemic, small placenta, and
thus a growth retarded fetus. As. programs of
normoglycemia have been the accepted norm
for pregnancies complicated by diabetes, the
observation that maternal glycemic levels affect
fetal size has emerged. In JOVANOVIC'S series [9]
of 22 vascularly compromised women, (patients
with retinopathy and nephropathy), the infant
birth weight correlated well with the third tri-
mester glycosylated hemoglobin levels; the
smaller babies were born of women with lower
glycosylated hemoglobin levels while the bigger
babies were born of women with higher levels.
The metabolic status of the infant at birth is
also related to blood sugar levels of the mother;
in fact, the latter's levels in the last days prior
to delivery affect fetal glucose homeostasis the
most [21]. Thus pre-delivery glucose control is
as important as that achieved during the entire
nine months.
In our experience, a creatinine clearance as low
as 40 ml/min does not affect the 24-hour insulin
requirement. We still see a first trimester insulin
requirement of 0.7 units/kg/24 hours and the
steady insulin increase throughout pregnancy
of 0.8 units/kg/24 hours at 26 weeks, 0.9 units/
kg/24 hours at 32 weeks, and 1.0 unit/kg/24
hours after the 35th week of gestation. Similar
to our diabetic patients with normal kidney
function, the insulin dose is best divided into
two-thirds in the morning, one-sixth before din-
ner and one sixth before bed. The two-thirds
in the morning is 2:1 NPH to regular; the one-
sixth before dinner is regular and one-sixth
before bed consists of NPH. Home blood-gluc-
ose-monitoring before and one hour after each
J. Perinat. Med. 14 (1986)
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meal guides the insulin adjustment to keep up
with the ever increasing insulin requirements of
pregnancy [8].
It is a well-known fact that the coexistence of
severe renal disease and pregnancy is usually
associated with a high rate of fetal wastage.
Moreover, a normal gestational course is de-
scribed as rare when preconception serum crea-
tinine is higher than 3.0 mg/dl and/or the BUN
is greater than 30 mg/dl [16]. KITZMILLER et
al [12] has emphasized the issue of perinatal
outcome in pregnancies complicated by diabetic
nephropathy. In a series of 36 patients with
nephropathy, spontaneous abortion occurred
in four, elective abortions in five, while the
rest delivered live infants after 27 weeks of
gestation. Of the 26 live births all survived the
perinatal period.
Examination of our series of women with dia-
betic nephropathy, all of whom had prepreg-
nancy normal glucose values and were sustain-
ed with normoglycemia throughout pregnancy,
allowed us to note a number of clinical findings:
first, normoglycemia removes the additional
risks and improves the outcome in these preg-
nancies in which superimposed hypertension
is not a concomitant risk factor. Second, our
findings suggest that creatinine clearance is not
worsened by the course of pregnancy in the
majority of women with diabetic nephropathy
and that proteinuria per se does not add addi-
tional risk to the pregnancy or outcome. More-
over, the usual trend of renal status improvment
retained post partum (table II). Nevertheless,
hypertension serves as a major pathogenic fac-
tor in these pregnancies since it is related to
increased proteinuria, decreased creatinine
clearance and'decreased fetal growth.
Three of our patients, one with inital hyperten-
sion of 140/90 mm Hg, developed super-
imposed hypertension of 150/100 — 160/
HOmmHg causing premature deliveries at
34—35 weeks. Thus, hypertension is a separate
risk factor which affects the pregnancy despite
normoglycemia.
5 Course of pregnancy
Antepartum monitoring for fetal distress is im-
portant in the management of diabetic pregnan-
cies especially those complicated by nephropa-
thy. Our experience supports the view that dia-
betic women with proteinuria, reduced crea-
tinine clearance and hypertension should be
admitted to the hospital for intensive obstetric
care at 26—28 weeks' gestation [5]. It seems
that intensive fetal monitoring by daily fetal
movements count, repeated NST followed by
CST when indicated, ultrasound imaging for
fetal growth and assessment of the fetal bio-
physical profile are the best predictors for fetal
condition. Fetal distress established on the basis
of diminution of fetal movements, suspicious
NST and positive CST was found in one of our
cases; we presume that prompt delivery of this
infant at 34 weeks' gestation prevented
stillbirth. The primary cesarean section rate in
diabetic pregnancies complicated by nephropa-
thy is high mainly due to the more frequent
need for premature delivery of a pregnant
woman at risk with an uripe cervix and a fragile
fetus [12]. In our group of White's class F
patients the cesarean section rate was 75 per-
cent, whereas our current primary rate for
patients in White's class B, C and D is 45
percent.
In recent years, the frequency of respiratory
distress syndrome (RDS) in infants of diabetic
mothers has shown a marked decline, from 23
percent to 8 percent [13]. This is related mainly
to the ability to carry pregnancies to term ac-
cording to tests of fetal well being and the
use of amniocentesis for assays of fetal lung
maturity. Nevertheless, the prevalence of RDS
remains higher (24%) in infants of class F dia-
betic mothers, which probably reflects the more
frequent need for premature delivery in this
group. Two infants in our series, delivered at
34 and 35 weeks' gestation developed RDS, one
despite maternal dexamethasone administra-
tion. At the time of follow-up examination no
infant had any signs of residual pulmonary
disease.
J. Perinat. Med. 14 (1986)
Dicker et al, Pregnancy complicated by diabetic nephropathy 305
In conclusion, the major predictors in the out-
come of pregnancies complicated by diabetic
nephropathy are the glycemic levels sustained
before and during pregnancy, and the degree
of superimposed hypertension. Nevertheless, it
is difficult to relate the improved perinatal out-
come in White's class F pregnancies to any one
factor. The features of our program which may
contribute to improved results, besides closer
attention to control of hyperglycemia and hy-
pertension, include motivation of patients to
maintain bed rest for prolonged periods, inten-
sive use of fetal monitoring tests, amniocentesis
for the evaluation of lung maturity and impro-
vements in neonatal care.
Summary
Diabetes mellitus is a high risk complication of pregnan-
cy and this is particularly true whenever long standing
diabetes is complicated by diabetic nephropathy.
Five cases are reported of diabetic pregnancy compli-
cated by nephropathy. Four women delivered healthy
babies, and one patient aborted spontaneously in the
9th week of gestation.
It is suggested that first and foremost in complicated
diabetic pregnancy strict normoglycemia should be ad-
hered to prior and all through pregnancy. Our findings
based on these cases also suggest that:
a) Pregnancy does not adversely affect the renal status
of a diabetic woman or vice versa. Creatinine clear-
ance is not worsened by the course of pregnancy in
the majority of these patients and proteinuria per
se does not add additional risks to pregnancy or
outcome.
b) Hypertension is a separate risk factor affecting the
pregnancy despite normoglycemia.
c) Motivation of these patients to maintain normogly-
cemia as well as bed rest for prolonged periods,
intensive use of fetal monitoring, evaluation of fetal
lung maturity and improved neonatal care may con-
tribute to improved perinatal outcome.
Keywords: Diabets mellitus, diabetic nephropathy, diabetic pregnancy.
Zusammenfassung
Schwangerschaft und diabetische Nephropathie
Ein Diabetes mellitus in der Schwangerschaft ist eine
mit einem hohen Risiko behaftete Komplikation. Dies
gilt insbesondere, wenn ein schon lange bestehender
Diabetes mit einer Nephropathie vorliegt.
Wir berichten über 5 Schwangerschaften mit Diabetes
und Nephropathie. Vier Frauen wurden von gesunden
Kindern entbunden. Bei einer Frau trat in der 9.
Schwangerschaftswoche ein Spontanabort auf.
Im Vordergrund steht, daß bei einer diabetischen
Schwangeren von Anfang an und über die gesamte
Schwangerschaft eine strikte Normoglykämie angestrebt
werden sollte. Darüberhinaus zeigen die untersuchten
Fälle folgendes auf:
a) Die Schwangerschaft hat keinen ungünstigen Ein-
fluß auf den renalen Status und umgekehrt. Bei der ·
Mehrzahl der Patientinnen verschlechterte sich die
Kreatinin-Clearance im Verlauf der Schwanger-
schaft nicht; eine Proteinurie per se stellt kein zu-
sätzliches Risiko für die Schwangerschaft oder den
Zustand des Neugeborenen dar.
b) Unabhängig von der Normoglykämie ist der Hyper-
tonus ein separater Risikofaktor mit Einfluß auf die
Schwangerschaft.
c) Zu einem verbesserten perinatalen Outcome können
beitragen: Motivierung der Patientinnen, eine Nor-
moglykämie aufrechtzuerhalten sowie Bettruhe über
längere Phasen einzuhalten, eine strenge Überwa-
chung der Schwangerschaft, Bestimmung der fetalen
Lungenreife und eine verbesserte Versorgung des
Neugeborenen.
Schlüsselwörter: Diabetes mellitus, diabetische Nephropathie, Diabetes and Schwangerschaft.
Resume
Grossesse compliquee de nephropathie diabetique
Le diabete est une complication ä haut risque de la
grossesse et celä est particulierement vrai lorsqu'une
longue histoire diabetique est compliquee par une neph-
ropathie diabetique.
On rapporte cinq cas de grossesse chez des diabetiques
compliquees de nephropathie. Quatre femmes ont accou-
che d'enfant bien portants et une patiente a avorte
spontanement au cours de la 9e semaine de gestation.
On suggere qu'en tout premier lieu, au cours des grosses-
J. Perinat. Med. 14 (1986)
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se avec diabete complique, il faut obtenir une glycemie
normale stricte avant et tout au long de la grossesse.
Nos donnees fondees sur ces cas suggerent egalement
que:
a) la grossesse n'affecte pas de fagon nefaste la fonction
renale de la femme diabetique et vice versa. La
clearance de la creatinine n'empire pas au cours de
la grossesse chez la majorite de ces patientes et la
proteinurie per se n'est pas un risque additionel
pour la grossesse ou son issue.
b) Phypertension est un facteur de risque separe au
coürs de la grossesse malgre une normoglycemie.
c) la motivation de ces patientes pour maintenir une
normoglycemie aussi bien qu'un repos prolonge au
lit, Putilisation intensive du monitoring foetal reva-
luation de la maturite pulmonaire foetal et des soins
neonataux approprie peuvent contribuer a assurer
un devenir neonatal ameliore.
Mots-cles: Diabete sucre, grossesse chez la diabetique, nephropathie diabetique.
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